Board of Trustees

Members-at-large

Mr. George Bickerstaff (Chairperson)

Partner and Managing Director,
M.M. Dillon & Co.
U.S.A.

Dr. J. Joseph Kim

President & CEO
Inovio Pharmaceuticals
U.S.A.

Prof. Fred N. Binka

Professor
University of Health and Allied Sciences
Ghana.

Dr. George R. Siber (Chair of Scientific Committee)

Chief Scientific Officer
ClearPath Vaccines
U.S.A.

Dr. Hanna Nohynek (Vice Chair)

Chief Physician & Team Leader
Vaccine Programme Development
National Institute for Health and Welfare (THL) Finland

Dr. Chris Varma

Co-founder, President, CEO & Chairman
Vision Medicines, Inc.
Boston, MA, U.S.A.

Mr. Malcolm Sweeney (Chair, Finance Committee)

Director of Finance EMEA
NComputing UK Ltd
UK

Dr. Ralf Clemens

Principal and Founder
Grid Europe Consulting
Germany

Ziad Ahmed A. Memish

Senior consultant Infectious Diseases
Director Research Department
Prince Mohamed Bin Abdulaziz Hospital
Ministry of Health, Saudi Arabia

Anthony Ford-Hutchinson

CSO, Ribonova, Inc
Independent Pharmaceutical Industry
USA

Representatives of WHO, UNDP, and Host Country (Republic of Korea)

Dr. Takeshi Kasai

Regional Director
International Vaccine Institute
WHO Western Pacific Regional Office (WPRO)
Manila, Philippines

Mr. Ki-hwan Kweon

Director General
International Organizations Bureau
Ministry of Foreign Affairs
Republic of Korea

Dr. Youngmee Jee

Director General
Center for Pathology and Immunology
National Institute of Health
Korea Centers for Disease Control & Prevention
Republic of Korea

United Nations Development Programme

Vacant

Representatives of State Parties to Establishment Agreement

Dr. Catharina Maijgren Steffensson

Associate Director, Medical Director Nordics
Sarepta Therapeutics
Sweden

Dr. Balram Bhargava

Secretary, Department of Health Research & Director General
Indian Council of Medical Research
India

Ex-officio

Dr. Jerome Kim

Director General
International Vaccine Institute

DONATE